iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) is a equity ETF from iShares tracking the Nasdaq US Biotechnology index through physical replication. Domiciled in Ireland and launched in 2018, the fund manages about 62 M € and charges a TER of 0.35% — 35 € per year on a €10,000 investment. Income is paid out to investors periodically (distributing).
| Vertex Pharmaceuticals Inc | 8.1% |
| Amgen Inc | 7.9% |
| Gilead Sciences Inc | 6.9% |
| Regeneron Pharmaceuticals Inc | 4.5% |
| Alnylam Pharmaceuticals Inc | 2.8% |
| Revolution Medicines Inc | 2.8% |
| Biogen Inc | 2.2% |
| Moderna Inc | 1.9% |
| Illumina Inc | 1.9% |
| argenx NV ADR | 1.8% |
| London Stock Exchange | BTEE | USD |
Source: the fund's KID and the issuer's official documentation — data verified as of July 2026.
This page is informational and is not an investment recommendation. Figures may contain errors or be out of date: always check the KID and the issuer's factsheet before any decision.